The tuberous sclerosis complex: Balancing proliferation and survival

Biochemical Society Transactions

Volumn 39, Issue 2, 2011, Pages 466-471

  Tomasoni, Romana ^a,b   Mondino, Anna ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Cell growth; Mammalian target of rapamycin (mTOR); Metabolism; Proliferation; Survival; Tuberous sclerosis

Indexed keywords

HAMARTIN; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; TUBERIN;

CELL DEATH; CELL GROWTH; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; GENE MUTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUBEROUS SCLEROSIS;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; HEALTH; HUMANS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

MAMMALIA;

EID: 79953172971     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390466     Document Type: Review

References (50)

1. Orlova, K.A. and Crino, P.B. (2010) The tuberous sclerosis complex. Ann. N.Y. Acad. Sci. 1184, 87-105
2. Zhang, H., Cicchetti, G., Onda, H., Koon, H.B., Asrican, K., Bajraszewski, N., Vazquez, F., Carpenter, C.L. and Kwiatkowski, D.J. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J. Clin. Invest. 112, 1223-1233
3. Benvenuto, G., Li, S., Brown, S.J., Braverman, R., Vass, W.C., Cheadle, J.P., Halley, D.J., Sampson, J.R., Wienecke, R. and DeClue, J.E. (2000) The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene 19, 6306-6316 (Pubitemid 32641844)
4. Chong-Kopera, H., Inoki, K., Li, Y., Zhu, T., Garcia-Gonzalo, F.R., Rosa, J.L. and Guan, K.L. (2006) TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase. J. Biol. Chem. 281, 8313-8316
5. Lee, D.F., Kuo, H.P., Chen, C.T., Hsu, J.M., Chou, C.K., Wei, Y., Sun, H.L., Li, L.Y., Ping, B., Huang, W.C. et al. (2007) IKKβ suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130, 440-455 (Pubitemid 47198298)
6. Manning, B.D., Tee, A.R., Logsdon, M.N., Blenis, J. and Cantley, L.C. (2002) Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/Akt pathway. Mol. Cell 10, 151-162 (Pubitemid 34876569)
7. Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K. et al. (2006) TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126, 955-968 (Pubitemid 44310775)
8. Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P. and Pandolfi, P.P. (2005) Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121, 179-193 (Pubitemid 40546387)
9. Potter, C.J., Pedraza, L.G. and Xu, T. (2002) Akt regulates growth by directly phosphorylating Tsc2. Nat. Cell Biol. 4, 658-665
10. Tee, A.R., Manning, B.D., Roux, P.P., Cantley, L.C. and Blenis, J. (2003) Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13, 1259-1268
11. Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K. and Avruch, J. (2005) Rheb binds and regulates the mTOR kinase. Curr. Biol. 15, 702-713
12. Bai, X., Ma, D., Liu, A., Shen, X., Wang, Q.J., Liu, Y. and Jiang, Y. (2007) Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. Science 318, 977-980 (Pubitemid 350098994)
13. Inoki, K., Li, Y., Xu, T. and Guan, K.L. (2003) Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17, 1829-1834 (Pubitemid 36944560)
14. Huang, J., Dibble, C.C., Matsuzaki, M. and Manning, B.D. (2008) The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol. Cell. Biol. 28, 4104-4115
15. Sarbassov, D.D., Ali, S.M., Kim, D.H., Guertin, D.A., Latek, R.R., Erdjument-Bromage, H., Tempst, P. and Sabatini, D.M. (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296-1302
16. Mak, B.C., Takemaru, K., Kenerson, H.L., Moon, R.T. and Yeung, R.S. (2003) The tuberin-hamartin complex negatively regulates β-catenin signaling activity. J. Biol. Chem. 278, 5947-5951
17. Kugoh, H., Kleymenova, E. and Walker, C.L. (2002) Retention of membrane-localized β-catenin in cells lacking functional polycystin-1 and tuberin. Mol. Carcinog. 33, 131-136
18. Nelson, W.J. and Nusse, R. (2004) Convergence of Wnt, β-catenin, and cadherin pathways. Science 303, 1483-1487
19. Mizuguchi, M. and Takashima, S. (2001) Neuropathology of tuberous sclerosis. Brain Dev. 23, 508-515 (Pubitemid 32999117)
20. Duvel, K., Yecies, J.L., Menon, S., Raman, P., Lipovsky, A.I., Souza, A.L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S. et al. (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39, 171-183
21. Shaw, R.J. and Cantley, L.C. (2006) Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441, 424-430
22. DeBerardinis, R.J., Lum, J.J., Hatzivassiliou, G. and Thompson, C.B. (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7, 11-20
23. Inoki, K., Zhu, T. and Guan, K.L. (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590 (Pubitemid 37506046)
24. Choo, A.Y., Kim, S.G., Vander Heiden, M.G., Mahoney, S.J., Vu, H., Yoon, S.O., Cantley, L.C. and Blenis, J. (2010) Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. Mol. Cell 38, 487-499
25. Soucek, T., Pusch, O., Wienecke, R., DeClue, J.E. and Hengstschlager, M. (1997) Role of the tuberous sclerosis gene-2 product in cell cycle control: loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J. Biol. Chem. 272, 29301-29308
26. Soucek, T., Yeung, R.S. and Hengstschlager, M. (1998) Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc. Natl. Acad. Sci. U.S.A. 95, 15653-15658
27. Ito, N. and Rubin, G.M. (1999) gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle. Cell 96, 529-539 (Pubitemid 29106840)
28. Orimoto, K., Tsuchiya, H., Kobayashi, T., Matsuda, T. and Hino, O. (1996) Suppression of the neoplastic phenotype by replacement of the Tsc2 gene in Eker rat renal carcinoma cells. Biochem. Biophys. Res. Commun. 219, 70-75
29. Jin, F., Wienecke, R., Xiao, G.H., Maize, Jr, J.C., DeClue, J.E. and Yeung, R.S. (1996) Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Proc. Natl. Acad. Sci. U.S.A. 93, 9154-9159
30. Chen, C., Liu, Y., Liu, R., Ikenoue, T., Guan, K.L. and Zheng, P. (2008) TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J. Exp. Med. 205, 2397-2408
31. Rachdi, L., Balcazar, N., Osorio-Duque, F., Elghazi, L., Weiss, A., Gould, A., Chang-Chen, K.J., Gambello, M.J. and Bernal-Mizrachi, E. (2008) Disruption of Tsc2 in pancreatic β cells induces β cell mass expansion and improved glucose tolerance in a TORC1-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 105, 9250-9255
32. Tee, A.R., Anjum, R. and Blenis, J. (2003) Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin. J. Biol. Chem. 278, 37288-37296
33. Hsieh, T.C., Nicolay, B.N., Frolov, M.V. and Moon, N.S. (2010) Tuberous sclerosis complex 1 regulates dE2F1 expression during development and cooperates with RBF1 to control proliferation and survival. PLoS Genet. 6, e1001071
34. Wienecke, R., Konig, A. and DeClue, J.E. (1995) Identification of tuberin, the tuberous sclerosis-2 product: tuberin possesses specific Rap1GAP activity. J. Biol. Chem. 270, 16409-16414
35. Yoshida, Y., Kawata, M., Miura, Y., Musha, T., Sasaki, T., Kikuchi, A. and Takai, Y. (1992) Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes. Mol. Cell. Biol. 12, 3407-3414
36. Kip1 levels in Tsc2-null cells via mTORC1-independent mechanisms: implications for cell proliferation and tumorigenesis. Oncogene 29, 6543-6556
37. Mak, B.C., Kenerson, H.L., Aicher, L.D., Barnes, E.A. and Yeung, R.S. (2005) Aberrant β-catenin signaling in tuberous sclerosis. Am. J. Pathol. 167, 107-116
38. Kip1 localization. Cancer Res. 69, 7224-7234
39. Ravitz, M.J., Chen, L., Lynch, M. and Schmidt, E.V. (2007) c-Myc repression of TSC2 contributes to control of translation initiation and Myc-induced transformation. Cancer Res. 67, 11209-11217 (Pubitemid 350248546)
40. Schmidt, E.V., Ravitz, M.J., Chen, L. and Lynch, M. (2009) Growth controls connect: interactions between c-myc and the tuberous sclerosis complex-mTOR pathway. Cell Cycle 8, 1344-1351
41. Polager, S. and Ginsberg, D. (2008) E2F: at the crossroads of life and death. Trends Cell Biol. 18, 528-535
42. Di Nardo, A., Kramvis, I., Cho, N., Sadowski, A., Meikle, L., Kwiatkowski, D.J. and Sahin, M. (2009) Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner. J. Neurosci. 29, 5926-5937
43. Kang, Y.J., Lu, M.K. and Guan, K.L. (2011) The TSC1 and TSC2 tumor suppressors are required for proper ER stress response and protect cells from ER stress-induced apoptosis. Cell Death Differ. 18, 133-144
44. Lee, C.H., Inoki, K., Karbowniczek, M., Petroulakis, E., Sonenberg, N., Henske, E.P. and Guan, K.L. (2007) Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53. EMBO J. 26, 4812-4823 (Pubitemid 350191300)
45. Stevens, C., Lin, Y., Harrison, B., Burch, L., Ridgway, R.A., Sansom, O. and Hupp, T. (2009) Peptide combinatorial libraries identify TSC2 as a death-associated protein kinase (DAPK) death domain-binding protein and reveal a stimulatory role for DAPK in mTORC1 signaling. J. Biol. Chem. 284, 334-344
46. Cao, Y., Kamioka, Y., Yokoi, N., Kobayashi, T., Hino, O., Onodera, M., Mochizuki, N. and Nakae, J. (2006) Interaction of FoxO1 and TSC2 induces insulin resistance through activation of the mammalian target of rapamycin/p70 S6K pathway. J. Biol. Chem. 281, 40242-40251
47. Harrington, L.S., Findlay, G.M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N.R., Cheng, S., Shepherd, P.R. et al. (2004) The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J. Cell Biol. 166, 213-223 (Pubitemid 38988774)
48. Shah, O.J., Wang, Z. and Hunter, T. (2004) Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr. Biol. 14, 1650-1656
49. Manning, B.D., Logsdon, M.N., Lipovsky, A.I., Abbott, D., Kwiatkowski, D.J. and Cantley, L.C. (2005) Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev. 19, 1773-1778 (Pubitemid 41126916)
50. Harvey, K.F., Mattila, J., Sofer, A., Bennett, F.C., Ramsey, M.R., Ellisen, L.W., Puig, O. and Hariharan, I.K. (2008) FOXO-regulated transcription restricts overgrowth of Tsc mutant organs. J. Cell Biol. 180, 691-696 (Pubitemid 351397767)